Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies
Clinical trial NCT03941626 · UNKNOWN
Trial details
- NCT number
- NCT03941626
- Sponsor
- Shenzhen BinDeBio Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2021-05-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.